Peritoneal carcinomatosis from ovarian cancer: the role of CT and [18F]FDG-PET/CT
- 26 September 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Abdominal Radiology
- Vol. 35 (6), 701-707
- https://doi.org/10.1007/s00261-009-9578-8
Abstract
Purpose The diagnosis of peritoneal carcinomatosis secondary to ovarian cancer is a real challenge in the cancer imaging field. In this retrospective study, we evaluate the accuracy of Single Detector Computed Tomography (SDCT), Multi Detector Computed Tomography (MDCT), and Positron Emission Tomography–Computed Tomography with F18-fluorodeoxyglucose ([18F]FDG-PET/CT) in the diagnosis of peritoneal seeding and we evaluate the possible applications of MDCT to predict the complete surgical removal of the peritoneal deposits. Methods and materials A total of 228 scans (91 SDCT, 89 MDCT, and 48 [18F]FDG-PET/CT) of patients with peritoneal carcinomatosis secondary to ovarian cancer proved at laparoscopy and confirmed by histopathology were retrospectively reviewed by two independent groups of Radiologists and Nuclear Medicine Physicians for the evaluation of ascites, peritoneal nodules, and omental cake signs. Results MDCT showed 81% of true positives, SDCT 72.5%, and [18F]FDG-PET/CT 77%. False negatives were 19% for MDCT, 27.5% for SDCT, and 23% for [18F]FDG-PET/CT. Conclusion From our results, we concluded that MDCT is the technique of choice in the diagnosis of peritoneal seeding, while [18F]FDG-PET/CT, though showing similar accuracy, remains the most accurate technique for monitoring therapeutic response and disease recurrence. MDCT could play an important role due to its ability to predict the possibility of complete surgical removal of disease thus influencing the treatment plan aimed to improve quality of life.Keywords
This publication has 20 references indexed in Scilit:
- Radiological staging of ovarian cancer: imaging findings and contribution of CT and MRIEuropean Radiology, 2007
- Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)Gynecologic Oncology, 2007
- Treatment goals in ovarian cancerInternational Journal of Gynecologic Cancer, 2005
- Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-AnalysisJournal of Clinical Oncology, 2002
- Clinical Value of Positron Emission Tomography with FDG for Recurrent Ovarian CancerAmerican Journal of Roentgenology, 2001
- Advanced ovarian cancerCurrent Treatment Options in Oncology, 2001
- Staging of Advanced Ovarian Cancer: Comparison of Imaging Modalities—Report from the Radiological Diagnostic Oncology GroupRadiology, 2000
- Diagnosis and Staging of Ovarian Cancer: Comparative Values of Doppler and Conventional US, CT, and MR Imaging Correlated with Surgery and Histopathologic Analysis—Report of the Radiology Diagnostic Oncology GroupRadiology, 1999
- Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience.Journal of Clinical Oncology, 1991
- DISTRIBUTION OF INTRA-ABDOMINAL MALIGNANT SEEDING: DEPENDENCY ON DYNAMICS OF FLOW OF ASCITIC FLUIDAmerican Journal of Roentgenology, 1973